Ultraschall Med 2021; 42(04): 437-438
DOI: 10.1055/a-1542-6288
DUDS meddelelser

Intestinal ultrasound in ulcerative colitis – an objective biomarker for treatment response?

Johan F.K.F. Ilvemark
Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
› Author Affiliations

The use of transabdominal intestinal ultrasound (IUS) as an objective biomarker of inflammation in ulcerative colitis (UC) is gaining acceptance [1]. IUS ability to correctly identify inflammation and extent of inflammation has been explained in several studies [2]. The advantages over endoscopy or other cross-sectional modalities are many; IUS is a non-invasive, preparation – and radiation-free, easily repeated and patient friendly modality [1]. When visualizing disease burden in real-time, clinicians can better explain and motivate treatment decisions, helping patients to understand their disease [3].



Publication History

Publication Date:
03 August 2021 (online)

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany